Chinese researchers at Huashan Hospital, an affiliate of Fudan University in Shanghai, have made a groundbreaking discovery in the fight against Parkinson's disease. According to a recent study published in the journal Science, the team, led by Yu Jintai, deputy head of the neurology department, identified FAM171A2 as a new therapeutic target for treating Parkinson's disease.
After five years of dedicated research, the team not only discovered FAM171A2 but also identified a candidate drug that has the potential to slow the progression of Parkinson's disease. This represents a significant advancement, as traditional treatments for Parkinson's typically focus on alleviating symptoms rather than halting disease progression.
The research was conducted under the auspices of the National Center for Neurological Diseases and the National Key Laboratory of Brain Function and Brain Diseases. Parkinson's disease is the second most common neurodegenerative disorder after Alzheimer's, profoundly impacting patients' daily lives.
Reference(s):
Chinese researchers find new target to treat Parkinson's disease
cgtn.com
